First Horizon Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$30.4K Buy
1,629
+558
+52% +$11.1K ﹤0.01% 1254
2025
Q1
$20.5K Buy
1,071
+96
+10% +$2.81K ﹤0.01% 1312
2024
Q4
$35.1K Buy
975
+214
+28% +$7.24K ﹤0.01% 1102
2024
Q3
$32.3K Buy
761
+143
+23% +$6.06K ﹤0.01% 1182
2024
Q2
$24.9K Buy
618
+74
+14% +$3.09K ﹤0.01% 1199
2024
Q1
$19.3K Buy
544
+31
+6% +$831 ﹤0.01% 1351
2023
Q4
$15.2K Buy
513
+314
+158% +$6.51K ﹤0.01% 1434
2023
Q3
$4.13K Buy
+199
New +$5.46K ﹤0.01% 1797
2023
Q1
Sell
-9
Closed -$405 2546
2022
Q4
$405 Sell
9
-40
-82% -$1.81K ﹤0.01% 2396
2022
Q3
$1K Sell
49
-39
-44% -$2.14K ﹤0.01% 2192
2022
Q2
$5K Sell
88
-24
-21% -$1.97K ﹤0.01% 1850
2022
Q1
$13K Buy
112
+1
+0.9% +$117 ﹤0.01% 1029
2021
Q4
$17K Hold
111
﹤0.01% 1339
2021
Q3
$13K Buy
111
+29
+35% +$3.19K ﹤0.01% 1443
2021
Q2
$8K Buy
82
+17
+26% +$1.52K ﹤0.01% 1415
2021
Q1
$6K Sell
65
-19
-23% -$1.77K ﹤0.01% 1425
2020
Q4
$8K Sell
84
-11
-12% -$1.13K ﹤0.01% 1126
2020
Q3
$10K Buy
95
+6
+7% +$630 ﹤0.01% 1016
2020
Q2
$9K Hold
89
﹤0.01% 1052
2020
Q1
$6K Hold
89
﹤0.01% 1084
2019
Q4
$5K Sell
89
-39
-30% -$2.4K ﹤0.01% 1275
2019
Q3
$8K Buy
+128
New +$8.17K ﹤0.01% 1133
2016
Q2
Sell
-19
Closed -$1K 1405
2016
Q1
$1K Hold
19
﹤0.01% 1296
2015
Q4
$2K Sell
19
-8
-30% -$794 ﹤0.01% 1175
2015
Q3
$2K Hold
27
﹤0.01% 1304
2015
Q2
$2K Buy
27
+1
+4% +$124 ﹤0.01% 1320
2015
Q1
$3K Hold
26
﹤0.01% 1323
2014
Q4
$3K Buy
+26
New +$3.6K ﹤0.01% 1317

Other funds holding TNDM

First Horizon Advisors's TNDM Position: Q2 2025 in Review

First Horizon Advisors increased its Tandem Diabetes Care (TNDM) stake by 52% in Q2 2025, buying an estimated $11.1K and bringing the position to 1,629 shares worth $30.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

First Horizon Advisors first reported a position in TNDM in Q4 2014 and has held it in 28 quarters since. The position peaked at $35.1K in Q4 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • First Horizon Advisors held 1,629 shares of Tandem Diabetes Care worth $30.4K as of Q2 2025.
  • First Horizon Advisors bought 558 Tandem Diabetes Care shares in Q2 2025, an estimated $11.1K.
  • Tandem Diabetes Care made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1254 holding.
  • First Horizon Advisors first reported a position in Tandem Diabetes Care in Q4 2014 and has held it in 28 quarters since.
  • First Horizon Advisors's Tandem Diabetes Care position peaked at $35.1K in Q4 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.